Cargando…
Long-Chain and Very Long-Chain Ceramides Mediate Doxorubicin-Induced Toxicity and Fibrosis
Doxorubicin (Dox) is a chemotherapeutic agent with cardiotoxicity associated with profibrotic effects. Dox increases ceramide levels with pro-inflammatory effects, cell death, and fibrosis. The purpose of our study was to identify the underlying ceramide signaling pathways. We aimed to characterize...
Autores principales: | Kretzschmar, Tom, Bekhite, Mohamed M., Wu, Jasmine M. F., Haase, Daniela, Förster, Martin, Müller, Tina, Nietzsche, Sandor, Westermann, Martin, Franz, Marcus, Gräler, Markus H., Schulze, P. Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584314/ https://www.ncbi.nlm.nih.gov/pubmed/34769283 http://dx.doi.org/10.3390/ijms222111852 |
Ejemplares similares
-
Differences in plasma levels of long chain and very long chain ceramides between African Americans and whites: An observational study
por: Buie, Joy N. Jones, et al.
Publicado: (2019) -
Role of Intracellular Lipid Logistics in the Preferential Usage of Very Long Chain-Ceramides in Glucosylceramide
por: Yamaji, Toshiyuki, et al.
Publicado: (2016) -
Long and Very-Long-Chain Ceramides Correlate with A More Aggressive Behavior in Skull Base Chordoma Patients
por: La Corte, Emanuele, et al.
Publicado: (2019) -
Long- and very long-chain ceramides are predictors of acute kidney injury in patients with acute coronary syndrome: the PEACP study
por: Liang, Lianjing, et al.
Publicado: (2023) -
Zymosan-Induced Murine Peritonitis Is Associated with an Increased Sphingolipid Synthesis without Changing the Long to Very Long Chain Ceramide Ratio
por: Pierron, Alix, et al.
Publicado: (2023)